Research Triangle Park, N.C.– The Council for Entrepreneurial Development (CED) today announced Monica Doss, the longtime president of CED, has submitted her resignation, to become effective on May 31, 2008. CED officials and Doss made a joint announcement at today’s regular meeting of the CED board. (more…)
Orlando, FL—The Tavistock Group says it will build a 100,000-square-foot $50 million wet lab and bio-tech incubator near the University of Central Florida College of Medicine and the Burnham Institute for Medical Research. (more…)
Florida finds fresh ways to push the industry
By John Carroll
The Sunshine State first hit the Top 5 in 2007. Last year we noted that Florida’s willingness to contribute hundreds of millions of dollars to attract satellite operations of leading research institutions was one of the boldest experiments yet in using state money to kick start its biotech industry. (more…)
Program Promotes New, Venture-Attractive Life Sciences Companies in the Southeast
Atlanta, GA – – Southeast BIO (SEBIO), a regional
nonprofit organization dedicated to fostering the growth of the Southeast’s life sciences industry, announced today its second annual BIO/Plan Competition. The year-long program has been designed and developed to help promote the creation of new, venture-attractive life science companies based in the Southeast. Working closely with tech transfer offices and entrepreneurs throughout the region, the competition pulls opportunities forward from our region’s research universities, research centers and experienced entrepreneurs.
(more…)
Research Triangle Park, NC — Icagen, Inc. (Nasdaq:ICGN) today announced the completion on February 13, 2008 of a previously announced sale of 5,847,953 shares of common stock to Pfizer Inc at a price of $1.71 per share, which was the closing bid price of the common stock as reported on the Nasdaq Global Market as of 4:00 p.m. Eastern Time on the business day preceding the date of Icagen’s put exercise pursuant to the Purchase Agreement dated August 13, 2007, resulting in gross proceeds to Icagen of approximately $10.0 million. (more…)
Ft. Lauderdale, FL — MAKO Surgical Corp. announced today the initial public offering of 5,100,000 shares of its common stock at a price of $10.00 per share, all of which shares are being offered by MAKO Surgical Corp. MAKO Surgical Corp. and a selling stockholder have granted the underwriters a 30-day option to purchase up to an additional 698,333 shares and 66,667 shares, respectively, at the initial public offering price to cover over-allotments, if any. (more…)
Atlanta, GA – Southeast BIO (SEBIO) today announced its 2008 SEBIO Investor Forum, set for December 4-5, 2008, at the Breakers Resort in Palm Beach, FL. The chair of this year’s event is David Day, Director, Office of Technology Licensing, University of Florida. (more…)
Welcome! We hope you enjoy our second edition of the Southeast Bio (SEBIO) Venture Wire. As part of our mission, one of SEBIO’s goals is to continue to provide industry specific content regarding the Southeast to those with an interest in the region’s life sciences community. As our second bi-monthly installment of the Southeast Bio Venture Wire reflects, the Southeast continues to increase its profile as one of the nation’s leading life science regions. (more…)
PITTSBORO, NC—Biolex, a company focused on producing proteins hard to synthesize via the plant Lemna, a duckweed, has withdrawn its registration for an $80 million IPO, citing “unfavorable market conditions.” (more…)
